Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Dae-Chang Park CEO | KRX SM Exchange | KR7000230003 ISIN |
KR Country | - Employees | - Last Dividend | 5 Mar 2020 Last Split | - IPO Date |
Ildong Holdings Co., Ltd., originally known as Ildong Pharmaceutical Co., Ltd. before its name change in August 2016, stands as a significant player in the pharmaceutical industry both within South Korea and on an international level. Founded in 1941 and headquartered in Seoul, South Korea, the company specializes in the development, manufacture, and supply of pharmaceutical products. Over the years, Ildong Holdings has diversified its offerings to include new drug development focused on combating resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing. Furthermore, the company extends its expertise to the research and production of health foods and ingredients, demonstrating its commitment to enhancing healthcare through innovation.